Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Formosa Laboratories

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Log in to download the data

    Company name Country Product name Certificate Numbers Status Issue Date Type Substance Number
    Formosa Laboratories
    Taiwan
    		Calcifediol monohydrate CEP 2019-163 - Rev 03 Valid 2025-07-31 Chemical 1295
    Formosa Laboratories
    Taiwan
    		Calcipotriol CEP 2007-243 - Rev 02 Valid 2025-07-15 Chemical 2011
    Formosa Laboratories
    Taiwan
    		Calcipotriol monohydrate CEP 2010-187 - Rev 01 Valid 2025-08-29 Chemical 2284
    Formosa Laboratories
    Taiwan
    		Calcitriol CEP 2009-377 - Rev 03 Valid 2025-07-16 Chemical and TSE 883
    Formosa Laboratories
    Taiwan
    		Calcitriol, Process 2 (F007V1) CEP 2020-150 - Rev 03 Valid 2025-07-11 Chemical 883
    Formosa Laboratories
    Taiwan
    		Leflunomide CEP 2009-035 - Rev 03 Valid 2025-07-09 Chemical 2330
    Formosa Laboratories
    Taiwan
    		Montelukast sodium R1-CEP 2013-278 - Rev 00 Valid 2021-07-23 Chemical 2583
    Formosa Laboratories
    Taiwan
    		Temozolomide CEP 2017-245 - Rev 02 Valid 2025-07-09 Chemical 2780
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.